Status:
ACTIVE_NOT_RECRUITING
Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Aarhus University Hospital
Odense University Hospital
Conditions:
Pediatric Cancer
Leukemia
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
The INTERACT study is a nation-wide, population-based randomized controlled trial to investigate the effects of 6-month integrative neuromuscular training during anti-cancer treatment on lower body mu...
Detailed Description
Improved childhood cancer survival rates call for novel strategies to reduce acute and long-term physical complications of anti-cancer treatment. Children with cancer have markedly impaired muscle st...
Eligibility Criteria
Inclusion
- All malign and benign disorders treated with chemotherapy and/or irradiation
Exclusion
- Severe mental and/or physical disability, i.e. participants where all types of physical training and testing of physical function are contraindicated
- terminal illness
- unable to communicate in Danish
Key Trial Info
Start Date :
January 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT04706676
Start Date
January 26 2021
End Date
September 1 2028
Last Update
June 11 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, 8200
2
Rigshospitalet
Copenhagen, Denmark, 2100
3
Odense University Hospital
Odense, Denmark, 5000